妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)多克隆抗體
Polyclonal Antibody to Pregnancy Associated Plasma Protein A (PAPPA)
PAPP-A; PAPA; ASBABP2; DIPLA1; IGFBP-4ase; PAPPA1; Pappalysin 1; Insulin-Like Growth Factor Binding Protein-4 Protease; Differentially Placenta 1 Expressed Protein
- 編號PAA800Hu02
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標(biāo)記物無標(biāo)記物
- 免疫原 RPA800Hu02-妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)重組蛋白
- 緩沖液成份0.01M 磷酸鹽緩沖液（pH7.4，containing 0.05% Proclin-300，50% glycerol）
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應(yīng)用WB,IHC; FCM
如果抗體需用于流式細胞術(shù)，請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 569 ¥ 1327 ¥ 1896 ¥ 4740 ¥ 18960
- 欲了解實際交易價格和更多情況，請與當(dāng)?shù)亟?jīng)銷商聯(lián)系!
-
產(chǎn)品包裝(模擬)
-
產(chǎn)品包裝(模擬)
-
DAB staining on IHC-P; Samples: Human Placenta Tissue; Primary Ab: 20μg/mL Rabbit Anti-Human PAPPA Antibody Second Ab: 2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody (Catalog: SAA544Rb19)
-
DAB staining on IHC-P;<br/>Sample: Human Placenta Tissue<br/>Primary Ab: 20μg/mL Rabbit Anti-Human PAPPA Antibody<br/>Control: Used PBS instead of primary antibody<br/>Second Ab: 2μg/mL HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody<br/>(Catalog: SAA544Rb19)
-
Figure. Western Blot; Sample: Recombinant PAPPA, Human.
-
Western Blot; Sample: Human Placenta lysate; <br/>Primary Ab: 1μg/mL Rabbit Anti-Human PAPPA Antibody<br/>Second Ab: 0.2μg/mL?HRP-Linked Caprine Anti-Rabbit IgG Polyclonal Antibody<br/>(Catalog: SAA544Rb19)
-
Human A549 cell was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.1% BSA-Triton X-100,then stained with 20μg/mL rabbit Anti-human PAPPA Polyclonal Antibody (Catalog PAA800Hu02, red histogram) or Isotype control antibody (Catalog IS067-Rb01, green histogram), followed by 1μg/mL FITC-conjugated Anti-rabbit IgG Secondary Antibody (Catalog SAA544Rb18).
-
通過ISO 9001、ISO 13485質(zhì)量體系認證
特異性
該抗體是針對PAPPA的兔多克隆抗體。在免疫組織化學(xué)染色和免疫印跡實驗中能識別PAPPA。
用法
Western blotting: 0.01-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Flow cytometry:20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復(fù)凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定，具體方法如下：在37°C孵育48小時，沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi)，在適當(dāng)?shù)臈l件下存儲，損失率低于5%。
贈品
增值服務(wù)
相關(guān)產(chǎn)品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應(yīng)用(僅供研究使用，不用于臨床診斷！) |
| RPA800Hu03 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA800Hu01 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| RPA800Hu05 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA800Hu01 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA800Hu02 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)活性蛋白 | Cell?culture;?Activity?Assays. |
| APA800Hu03 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA800Hu04 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| APA800Hu04 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)活性蛋白 | Cell?culture;?Activity?Assays. |
| RPA800Hu02 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA800Hu01 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)多克隆抗體 | WB; IHC; ICC; IP. |
| PAA800Hu02 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)多克隆抗體 | WB,IHC; FCM |
| PAA800Hu03 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)多克隆抗體 | WB; IHC; ICC; IP. |
| LAA800Hu71 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)多克隆抗體(生物素標(biāo)記) | WB; IHC; ICC. |
| MAA800Hu21 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA800Hu22 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)單克隆抗體 | WB; IHC; ICC; IP. |
| MAA800Hu24 | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)單克隆抗體 | WB; IHC; ICC; IP. |
| SEA800Hu | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
| LMA800Hu | 妊娠關(guān)聯(lián)血漿蛋白A(PAPPA)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
| 雜志 | 參考文獻 |
| American Journal of Physiology-Endocrinology and Metabolism | Hyperandrogenism and insulin resistance induce gravid uterine defects in association with mitochondrial dysfunction and aberrant ROS production [Pubmed: 30860876] |
留言咨詢
